The state of lipid peroxidation processes and the antioxidant defense system in obstructive sleep breathing disorders


DOI: https://dx.doi.org/10.18565/therapy.2020.5.102-106

Miroshnichenko A.I., Petrova A.A., Ivanov K.M., Krasikov S.I.

Orenburg State Medical University of the Ministry of Healthcare of Russia
The aim is to identify peculiarities of changes in the intensity of lipid peroxidation (LP) processes and the activity of antioxidant defense factors in obstructive sleep breathing disorders (OSBD) of varying severity.
Material and methods. 48 patients were examined complaining about snoring and excessive daytime sleepiness. They were divided into 4 groups. The 1st (control) group consisted of patients without OSBD (n=16), the 2nd – with mild OSBD (n=16), the 3rd – with moderate OSBD (n=8), and the 4th – severe OSBD (n=8). Cardiorespiratory monitoring was performed for OSBD detection; the severity of OSBD was estimated by the apnea/hypopnea index (AHI). The state of lipid peroxidation processes was evaluated by the content of diene conjugates (DC) and malondialdehyde (MDA) in the blood serum, the state of antioxidant protection – by changes in the activity of superoxide dismutase (SOD) and catalase (CAT). Data were considered reliable at a significance level of p <0,05.
Results. In all groups, indicators of saturation of blood oxygen during wakefulness (Bas SpO2) were within the reference values and did not significantly differ. The values of the minimum SpO2 (Min SpO2) during sleep in patients of the 2nd and 3rd groups did not significantly differ between themselves and the values of patients in the control group. In patients of the 4th group, Min SpO2 was lower than in patients of the control and 2nd groups, respectively, by 11,9 (p <0,001) and 8,8% (p=0,002). In the control group, the values of the degree of reduction of SpO2 (∆SpO2) were the smallest. Index ∆SpO2 in the 4th group was higher by 86,9% than in the control (p=0,0001) and 66,6% than in the 2nd group (p=0,002), however, the differences in Δ SpO2 in the control, 2nd and 3rd groups were not significant. The concentration of DC did not significantly differ in the examined groups. The increase in AHI was accompanied by an increase in the concentration of MDA: in patients of the 3rd group, its values were 25,1% higher than in patients of the control group (p=0,007), and 48,4% higher compared to patients of the 2nd group (p=0,005); in patients of the 4th group – by 45,5 (p=0,004) and 72,5% (p=0,003), respectively. In the control group, the maximum values of SOD and CAT activity in serum were observed. In the 2nd group, the activity of CAT and SOD was significantly lower by 13,6 and 13,5%, respectively, than in the control group; in the 3rd group – by 14,7 and 33,7%, respectively; in the 4th group – by 19,4 and 35,9%, respectively.
Conclusion. Hypoxia, increasing with OSBD progression, leads to an increase in the activity of LP processes due to an increase in the concentration of MAD in the blood serum, as well as to a decrease in the activity of antioxidant defense factors SOD and CAT. Performing individual therapeutic measures aimed at preventing the development of episodes of respiratory arrest in sleep and hypoxemia can lead to the normalization of LP processes and the antioxidant defense system.
Keywords: obstructive sleep disturbances, lipid peroxidation, antioxidant defense system

Literature



  1. Чазова И.Е., Литвин А.Ю. Синдром обструктивного апноэ сна и связанные с ним сердечно-сосудистые осложнения. Медицина критических состояний. 2010; 1: 3–10. [Chazova I.E., Litvin A.Yu. Obstructive sleep apnea syndrome and associated cardiovascular complications. Meditsina kriticheskikh sostoyaniy. 2010; 1: 3–10 (In Russ.)]

  2. Ан Г.В., Пальман А.Д., Даниляк И.Г. Свободно-радикальные процессы и их динамика при лечении терапевтических больных с синдромом обструктивного апноэ во сне. Клиническая геронтология. 2005; 5: 20–24. [An G.V., Palman A.D., Danilyak I.G. Free radical processes and their dynamics in the treatment of therapeutic patients with obstructive sleep apnea. Klinicheskaya gerontologiya. 2005; 5: 20–24. (In Russ.)]

  3. Ntalapascha M., Makris D., Kyparos A. et al. Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath. 2013; 17(2): 549–55. doi: 10.1007/s11325-012-0718-y.

  4. Simiakakis M., Kapsimalis F., Chaligiannis E. et al. Lack of effect of sleep apnea on oxidative stress in obstructive sleep apnea syndrome (OSAS) patients. PLoS One. 2012; 7(6): e39172. doi: 10.1371/journal.pone.0039172.

  5. Placer Z. Lip peroxidation systeme im biologischen material. Nahrung. 1968; Bd. 12: 679.

  6. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 2: 351–58. doi:10.1016/0003-2697(79)90738-3.

  7. Cирота Т.В. Новый подход в исследовании процесса аутоокисления адреналина и использование его для измерения активности супероксиддисмутазы. Вопросы медицинской химии. 1999; 3: 263–272. [ Sirota T.V. A new approach to the study of the process of autooxidation of adrenaline and its use to measure the activity of superoxide dismutase. Voprosy meditsinskoy khimii. 1999; 3: 263–272 (In Russ.)]

  8. Zuck H. Catalase. Methods of enzymatic analysis. Pergamon Press. 1963: 885–94.

  9. Lloret A., Buj J., Badia M.C. et al. Obstructive sleep apnea: arterial oxygen desaturation coincides with increases in systemic oxidative stress markers measured with continuous monitoring. Free Radic Biol Med. 2007; 42(6): 893–94. doi: 10.1016/j.freeradbiomed.2006.10.051.

  10. Lavie L., Vishnevsky A., Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep. 2004; 27: 123–28.

  11. Canino B., Hopps E., Calandrino V. et al. Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome. Clin Hemorheol Microcirc. 2015; 59: 45–52. doi: 10.3233/CH-141815.

  12. Мадаева И.М., Петрова В.А., Колесникова Л.И., Шевырталова О.Н. Синдром обструктивного апноэ/гипопноэ сна и перекисное окисление липидов. Пульмонология. 2009; 2: 65–69. [Madaeva I.M., Petrova V.A., Kolesnikova L.I., Shevyrtalova O.N. Obstructive sleep apnea/hypopnea syndrome and lipid peroxidation. Pul'monologiya. 2009; 2: 65–69 (In Russ.)].


About the Autors


Anastasia I. Miroshnichenko, postgraduate student of the Department of propaedeutics of internal diseases of Orenburg State Medical University of the Ministry of Healthcare of Russia. Address: 460001, Orenburg, 27 2nd Pugachevskaya Str. Tel.: +7 (912) 352-27-70. E-mail: miroshni4enko.nast@yandex.ru
Alena A. Petrova, assistant of the Department of chemistry of Orenburg State Medical University of the Ministry of Healthcare of Russia. Address: 460000, Orenburg, 7 Parkovy drive. Tel.: +7 (922) 836-91-81. E-mail: k_chemistry@orgma.ru
Konstantin M. Ivanov, MD, professor, head of the Department of propaedeutics of internal diseases of Orenburg State Medical University of the Ministry of Healthcare of Russia. Address: 460022, Orenburg, 8/1 Narodnaya Str. Tel.: +7 (987) 340-39-94. E-mail: kmiwanov@mail.ru
Sergey I. Krasikov, MD, professor, head of the Department of chemistry of Orenburg State Medical University of the Ministry of Healthcare of Russia. Address: 460000, Orenburg, 7 Parkovy drive. Tel.: +7 (922) 625-01-46. E-mail: k_chemistry@orgma.ru


Бионика Медиа